Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.15 - $7.94 $92,030 - $231,975
-29,216 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$6.18 - $14.44 $14,813 - $34,612
2,397 Added 8.94%
29,216 $181,000
Q4 2021

Feb 14, 2022

BUY
$7.8 - $14.38 $32,580 - $60,065
4,177 Added 18.45%
26,819 $381,000
Q3 2021

Nov 12, 2021

BUY
$7.76 - $29.37 $175,701 - $664,995
22,642 New
22,642 $181,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $75.4M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.